Hydroxyapatite (HA) coated liposomes (HACL) have been successfully manufactured and filled with a model hydrophobic (lipophilic) drug, indomethacin (IMC). These HACL particles have been characterized in terms of particle size and z-potential. The liposomes are formed from 1,2-dimyristoyl-sn-glycero-
Parameter estimation methodology in a model of hydrophobic drug release from a polymer coating
β Scribed by Rachael W. Sirianni; Eun-Hyun Jang; Kathleen M. Miller; W. Mark Saltzman
- Book ID
- 113693126
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 832 KB
- Volume
- 142
- Category
- Article
- ISSN
- 0168-3659
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The timeβdependent local drug delivery from drugβeluting stents (DES) plays a critical role in reducing restenosis in intravascular stenting. To better understand the basic mechanism of drug release for certain polymerβdrugβcoated DES platforms, a cylindrical diffusion model was applied
## Abstract Biodegradable polymeric coatings on cardiovascular stents can be used for local delivery of therapeutic agents to diseased coronary arteries after stenting procedures. This can minimize the occurrence of clinically adverse events such as restenosis after stent implantation. A validated
## Abstract Many factors affect the rate of drug release from biodegradable polymers. Here, we focus on investigating the effect of drug type on the degradation of P(DL)LGA 53/47 films and their ultimate release profiles. A freely waterβsoluble drug (metoclopramide monohydrochloride) exhibited an i